Clearline Capital LP Biomarin Pharmaceutical Inc Transaction History
Clearline Capital LP
- $686 Million
- Q4 2024
A detailed history of Clearline Capital LP transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Clearline Capital LP holds 377,482 shares of BMRN stock, worth $22.1 Million. This represents 3.61% of its overall portfolio holdings.
Number of Shares
377,482
Previous 319,772
18.05%
Holding current value
$22.1 Million
Previous $22.5 Million
10.39%
% of portfolio
3.61%
Previous 0.99%
Shares
2 transactions
Others Institutions Holding BMRN
# of Institutions
631Shares Held
184MCall Options Held
2MPut Options Held
1.67M-
Black Rock Inc. New York, NY22.7MShares$1.33 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.4MShares$1.14 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA18.2MShares$1.07 Billion0.94% of portfolio
-
Dodge & Cox San Francisco, CA14.7MShares$865 Million0.61% of portfolio
-
Capital Research Global Investors Los Angeles, CA13MShares$762 Million0.18% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $10.9B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...